Post-EASL 2026 Highlights and Clinical Implications

Webinar - June 11, 2026

Time 12:00 - 13:25

Place: Online

This educational webinar will highlight key insights from EASL 2026, with a focus on clinically relevant updates across liver disease.

The session will cover general hepatology, cholestatic and immunemediated liver diseases, as well as cirrhosis and liver transplantation. Nordic experts will share their perspectives on recent data and its implications for clinical practice. The webinar will conclude with an interactive Q&A session.

Agenda

12:00 - 12:05
Welcome & Introduction
Moderator TBC
12:05 - 12:25
General hepatology (incl. MASLD, ALD, portal hypertension)
Dr. Anna Cederborg, Sahlgrenska University Hospital, Sweden
12:25 - 12:45
Cholestatic and immune-mediated liver diseases
Dr. Josefin Kestad, Skåne University Hospital, Sweden
12:45 - 13:05
Cirrhosis and liver transplantation
Dr. Fredrik Åberg, Helsinki University Hospital, Finland
13:05 - 13:25
Q&A

Sign up

IPSEN AB will use the information you provide on this form to be in touch with you regarding this meeting and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

For more information about our privacy practices please visit our website. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

* indicates required

Dr. Anna Cederborg
Sahlgrenska University Hospital
Sweden

Speaker

Dr. Josefin Kestad
Skåne University Hospital
Sweden

Speaker

Dr. Fredrik Åberg
Helsinki University Hospital
Finland

Speaker

Moderator TBC